Akebia Therapeutics, Inc.AKBANASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank77
Studio
Year-over-Year Change

Return on equity

Percentile
P77
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-16.39%-111.6%
2024141.12%-16.9%
2023169.78%+109.4%
2022-1801.64%-372.8%
2021-381.07%-145.2%
2020-155.42%-119.4%
2019-70.84%-162.1%
2018-27.03%+58.1%
2017-64.45%+67.7%
2016-199.28%-